Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCRAPAN: Carboplatin-Paclitaxel Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
NCT04016142Phase 2Terminated
- Sponsor
- Centre Oscar Lambret
- Start
- Jul 2020
- Primary completion
- Jan 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in Cervical Cancer (CC), sponsored by Centre Oscar Lambret. Started Jul 2020; status: terminated.
02
Drugs
carboplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04016142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04016142.